These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27145952)

  • 41. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
    Breuer RH; Snijders PJ; Smit EF; Sutedja TG; Sewalt RG; Otte AP; van Kemenade FJ; Postmus PE; Meijer CJ; Raaphorst FM
    Neoplasia; 2004; 6(6):736-43. PubMed ID: 15720799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and Functional Characterization of a New Splicing Variant of EZH2 in the Central Nervous System.
    Li D; Wang HL; Huang X; Gu X; Xue W; Xu Y
    Int J Biol Sci; 2019; 15(1):69-80. PubMed ID: 30662348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polycomb Ezh2 controls the fate of GABAergic neurons in the embryonic cerebellum.
    Feng X; Juan AH; Wang HA; Ko KD; Zare H; Sartorelli V
    Development; 2016 Jun; 143(11):1971-80. PubMed ID: 27068104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation.
    Heinen A; Tzekova N; Graffmann N; Torres KJ; Uhrberg M; Hartung HP; Küry P
    Glia; 2012 Nov; 60(11):1696-708. PubMed ID: 22821416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer.
    Yoon KA; Gil HJ; Han J; Park J; Lee JS
    J Thorac Oncol; 2010 Jan; 5(1):10-6. PubMed ID: 19901851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
    Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
    Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of methyltransferase activity of enhancer of zeste 2 leads to enhanced lipid accumulation and altered chromatin status in zebrafish.
    den Broeder MJ; Ballangby J; Kamminga LM; Aleström P; Legler J; Lindeman LC; Kamstra JH
    Epigenetics Chromatin; 2020 Feb; 13(1):5. PubMed ID: 32051014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
    Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
    Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hedgehog signaling is required for differentiation of endocardial progenitors in zebrafish.
    Wong KS; Rehn K; Palencia-Desai S; Kohli V; Hunter W; Uhl JD; Rost MS; Sumanas S
    Dev Biol; 2012 Jan; 361(2):377-91. PubMed ID: 22119054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.
    Dreger H; Ludwig A; Weller A; Baumann G; Stangl V; Stangl K
    Genomics; 2016 Apr; 107(4):145-9. PubMed ID: 26853880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors.
    Zhang N; Zeng Z; Li S; Wang F; Huang P
    Sci Rep; 2018 Aug; 8(1):12331. PubMed ID: 30120321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.
    Jacobsen JA; Woodard J; Mandal M; Clark MR; Bartom ET; Sigvardsson M; Kee BL
    J Immunol; 2017 Jun; 198(12):4682-4691. PubMed ID: 28490575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Programmed cell senescence in skeleton during late puberty.
    Li C; Chai Y; Wang L; Gao B; Chen H; Gao P; Zhou FQ; Luo X; Crane JL; Yu B; Cao X; Wan M
    Nat Commun; 2017 Nov; 8(1):1312. PubMed ID: 29101351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.